FDA permits marketing of devices to create arteriovenous fistula
(HealthDay)—The U.S. Food and Drug Administration has permitted marketing of two catheter-based devices designed to create an arteriovenous (AV) fistula in patients with chronic kidney disease in need of hemodialysis.
Jul 4, 2018
0
0